People · Operator
Named in public records as an officer, director or promoter · active 2020–2022 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Mitosense, Inc. | — | Biotechnology | Seed | $4.4M | $23.0M | 2020 |
Andrew E. Finn at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Andrew E. Finn on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Tidal W. McCoy | 1 | 2 |
| Brent Segal | 1 | 1 |
| Catherine C. Baucom | 1 | 1 |
| Van D. Hipp Jr. | 1 | 1 |
| Xianpeng D. Jiang | 1 | 1 |
| Catherine M. Baucom | 1 | 1 |
| Xianpeng M. Jiang | 1 | 1 |
| Brent M. Segal | 1 | 1 |
| Catherine R. Baucom | 1 | 1 |
| Richard E. Waldo | 1 | 1 |
| Carla R. York | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.